Literature DB >> 10047563

Cytokine responses during mucosal infections: role in disease pathogenesis and host defence.

C Svanborg1, G Godaly, M Hedlund.   

Abstract

Mucosal pathogens use diverse and highly specific molecular mechanisms to activate mucosal inflammation. It may even be argued that their virulence depends on the inflammatory response that they induce. Some bacteria target epithelial cells and trigger them to produce inflammatory mediators but others cross the mucosa and activate macrophages or dendritic cells. Although systemic release of inflammatory mediators causes many symptoms and signs of infection, local chemokine production leads to the recruitment of inflammatory cells and lymphocytes that participate directly in the clearance of bacteria from mucosal sites. In this way, mucosal inflammation is a two-edged sword responsible for disease associated tissue destruction and crucial for the antimicrobial defence. Understanding of these pathways should create tools to enhance the defence and interfere with disease.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10047563     DOI: 10.1016/s1369-5274(99)80017-4

Source DB:  PubMed          Journal:  Curr Opin Microbiol        ISSN: 1369-5274            Impact factor:   7.934


  50 in total

Review 1.  Probiotics in the management and prevention of atopy.

Authors:  John Bienenstock; Ryan E Wiley; G Scott Neigh; Susan Waserman; Paul Keith
Journal:  Clin Rev Allergy Immunol       Date:  2002-06       Impact factor: 8.667

Review 2.  The bactericidal/permeability-increasing protein (BPI) in infection and inflammatory disease.

Authors:  Hendrik Schultz; Jerrold P Weiss
Journal:  Clin Chim Acta       Date:  2007-07-13       Impact factor: 3.786

3.  Modelling dynamics of the type I interferon response to in vitro viral infection.

Authors:  Tom J Howat; Cristina Barreca; Peter O'Hare; Julia R Gog; Bryan T Grenfell
Journal:  J R Soc Interface       Date:  2006-10-22       Impact factor: 4.118

4.  Host microarray analysis reveals a role for the Salmonella response regulator phoP in human macrophage cell death.

Authors:  C S Detweiler; D B Cunanan; S Falkow
Journal:  Proc Natl Acad Sci U S A       Date:  2001-04-24       Impact factor: 11.205

5.  Uropathogenic E. coli promote a paracellular urothelial barrier defect characterized by altered tight junction integrity, epithelial cell sloughing and cytokine release.

Authors:  M W Wood; E B Breitschwerdt; S K Nordone; K E Linder; J L Gookin
Journal:  J Comp Pathol       Date:  2011-10-19       Impact factor: 1.311

6.  Toll-like receptors TLR2 and TLR4 initiate the innate immune response of the renal tubular epithelium to bacterial products.

Authors:  P Chowdhury; S H Sacks; N S Sheerin
Journal:  Clin Exp Immunol       Date:  2006-08       Impact factor: 4.330

7.  Identification of genes subject to positive selection in uropathogenic strains of Escherichia coli: a comparative genomics approach.

Authors:  Swaine L Chen; Chia-Seui Hung; Jian Xu; Christopher S Reigstad; Vincent Magrini; Aniko Sabo; Darin Blasiar; Tamberlyn Bieri; Rekha R Meyer; Philip Ozersky; Jon R Armstrong; Robert S Fulton; J Phillip Latreille; John Spieth; Thomas M Hooton; Elaine R Mardis; Scott J Hultgren; Jeffrey I Gordon
Journal:  Proc Natl Acad Sci U S A       Date:  2006-04-03       Impact factor: 11.205

8.  Selective deletion of CD8(+) cells upregulated by caspases-1 via IL-18 in mice immunized with major outer membrane protein of Shigella dysenteriae 1 following infection.

Authors:  Ashim Kumar Bagchi; Ajoy Kumar Sinha; Rushita Adhikari; Pradip Maiti; Joydeep Mukherjee; Arpita Panda; Dhira Rani Saha
Journal:  J Clin Immunol       Date:  2010-01-19       Impact factor: 8.317

9.  Live Lactobacillus rhamnosus [corrected] is essential for the inhibitory effect on tumor necrosis factor alpha-induced interleukin-8 expression.

Authors:  Donglai Ma; Paul Forsythe; John Bienenstock
Journal:  Infect Immun       Date:  2004-09       Impact factor: 3.441

Review 10.  Using DNA microarrays to study host-microbe interactions.

Authors:  C A Cummings; D A Relman
Journal:  Emerg Infect Dis       Date:  2000 Sep-Oct       Impact factor: 6.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.